Company family
Eumedica: medicine shortages
As of 2 Nov 2026, 6 Eumedica products have a reported shortage across 2 countries, covering 4 medicines.
Products short6rank #278 of 464
Medicines4active ingredients
Countries2/16
New in 90 days2+2 vs market pace
Typical duration2.2 yearsmedian so far
Manufacturing40%demand-driven 0%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changes| Date | Country | Medicine | Change |
|---|---|---|---|
| 2 Nov | BE | Somatostatin Somatostatine-Belpharma 3 mg inf. sol. (pwdr.) i.v. amp. 3 mg + 1 ml | return pushed back 31 Oct → 16 Nov |
Open shortages over time
Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Temocillin | 2 | 4 Oct 2026 | Manufacturing problem | 1/16 | |
| Urokinase | 2 | 12 Oct 2022 | Other | 3/16 | |
| Somatostatin | 1 | 20 Feb 2023 | Other | 2/16 | |
| Sulfamethoxazole and Trimethoprim | 1 | 16 Feb 2026 | Not stated | 5/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.